Gilead Sciences Inc
NASDAQ: GILD
$91.69
+$1.47 (+1.6%)
Closing Price on November 6, 2024
GILD Articles
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia, Gilead Sciences, Goodyear, Philip Morris, Target and...
Published:
Last Updated:
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover...
Published:
Last Updated:
Here are 13 dirt cheap value stocks that are valued at less than 10 times earnings and that also pay steady dividends deemed to be safe as of mid-2019.
Published:
Last Updated:
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
These five top stocks to Buy have solid upside potential, and some of them appear to have put some past issues that burdened share price behind.
Published:
Last Updated:
It’s no simple task for a biotech giant to try to sell itself to investors as a value stock. That has been the case for some time when it comes to Gilead Sciences, Inc. (NASDAQ: GILD). After a long...
Published:
Last Updated:
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
Published:
Last Updated:
Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value going forward.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Gilead Sciences, Nordstrom, Novartis, Tesla, Under Armour, Walt Disney and Wendy's.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated: